Matinas biopharma to present at the needham virtual healthcare conference

Bedminster, n.j., april 06, 2022 (globe newswire) -- matinas biopharma (nyse amer: mtnb), a clinical-stage biopharmaceutical company focused on redefining the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal (lnc) platform technology, announced today that jerry jabbour, chief executive officer, has been invited to present at the 21st annual needham virtual healthcare conference on wednesday, april 13, 2022, at 3:00 p.m. et.
MTNB Ratings Summary
MTNB Quant Ranking